Literature DB >> 26596733

Fucosyltransferase 8 expression in breast cancer patients: A high throughput tissue microarray analysis.

Liling Yue1, Cuicui Han2, Zubin Li3, Xin Li3, Deshui Liu4, Shulin Liu2, Haitao Yu5.   

Abstract

The aim of this study was to compare the expression of fucosyltransferase 8 (FUT8) in breast cancer tissue and to investigate the relationship between this marker with tumor progression and its applicability to differential diagnosis. An immunohistochemical study was performed for FUT8 using the tissue microarray technique. In addition, the mRNA and protein levels of FUT8 in the tissue were also tested by real-time PCR and Western blot. There was a significant difference in cytoplasmic expression of FUT8 between breast cancer tissue and matched normal tissue (p<0.001). The percent of FUT8 staining in breast cancer tissues ranging from negative, weak positive, positive and strong positive were 2.7%, 40.2%, 54% and 3.2%, respectively. High FUT8 protein expression correlated with lymphatic metastasis (p=0.008) and with stage status (p=0.039). We detected that reduced FUT8 expression correlated with disease-free survival (p=0.02) and overall survival (p=0.04) of breast cancer patients. Expression of FUT8 can stratify breast cancer tissue and may be considered a prognostic marker for breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26596733     DOI: 10.14670/HH-11-693

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  14 in total

Review 1.  Novel approaches to target the microenvironment of bone metastasis.

Authors:  Lorenz C Hofbauer; Aline Bozec; Martina Rauner; Franz Jakob; Sven Perner; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2021-04-19       Impact factor: 66.675

Review 2.  Glycosylation and its implications in breast cancer.

Authors:  Danielle A Scott; Richard R Drake
Journal:  Expert Rev Proteomics       Date:  2019-07-25       Impact factor: 3.940

3.  α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).

Authors:  Fengzhou Li; Shilei Zhao; Yanwei Cui; Tao Guo; Jiaqi Qiang; Qiang Xie; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu; Taihua Wu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

4.  Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway.

Authors:  Hong-Fang Yang; Ming Yu; Hui-Dan Jin; Jia-Qi Yao; Zhi-Li Lu; Iddrisu B Yabasin; Qiu Yan; Qing-Ping Wen
Journal:  Front Physiol       Date:  2017-07-26       Impact factor: 4.566

Review 5.  FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment.

Authors:  Chengcheng Liao; Jiaxing An; Suqin Yi; Zhangxue Tan; Hui Wang; Hao Li; Xiaoyan Guan; Jianguo Liu; Qian Wang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

6.  Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells.

Authors:  Jia Guo; Changmei Liu; Xiaoman Zhou; Xiaoqiang Xu; Linhong Deng; Xiang Li; Feng Guan
Journal:  Int J Mol Sci       Date:  2017-08-01       Impact factor: 5.923

7.  FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.

Authors:  Cheng-Fen Tu; Meng-Ying Wu; Yuh-Charn Lin; Reiji Kannagi; Ruey-Bing Yang
Journal:  Breast Cancer Res       Date:  2017-10-05       Impact factor: 6.466

8.  Enhanced motility and proliferation by miR-10b/FUT8/p-AKT axis in breast cancer cells.

Authors:  Dong Guo; Jia Guo; Xiang Li; Feng Guan
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

9.  Partial silencing of fucosyltransferase 8 gene expression inhibits proliferation of Ishikawa cells, a cell line of endometrial cancer.

Authors:  Hana Shimoyama; Toshiaki K Shibata; Masahiko Ito; Tomoaki Oda; Toshiya Itoh; Mari Mukai; Madoka Matsuya-Ogawa; Masashi Adachi; Hirotake Murakami; Takeshi Nakayama; Kazuhiro Sugihara; Hiroaki Itoh; Tetsuro Suzuki; Naohiro Kanayama
Journal:  Biochem Biophys Rep       Date:  2020-02-12

Review 10.  Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucose.

Authors:  Yuki Ohkawa; Yoichiro Harada; Naoyuki Taniguchi
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.